# SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting

**Authors:** Yue Zhang, Carlos Silvestre-Roig, Han Fu, Haleh Alimohamadi, Taraknath Mandal, Jonathan W. Chen, Elizabeth Wei-Chia Luo, Jaime de Anda, Anna Lívia Linard Matos, Mathis Richter, Anna Mennella, HongKyu Lee, Liana C. Chan, Yingrui Wang, Naixin Wang, Hongyu Wang, Xiaohan Wang, Calvin K. Lee, Susmita Ghosh, Tsutomu Matsui, Thomas M. Weiss, Tiannan Guo, Maomao Zhang, Dapeng Li, Matthew C. Wolfgang, Robert S. Hagan, Melody M. H. Li, Matthias Gunzer, Albert Sickmann, Loredana Frasca, Michael R. Yeaman, Roberto Lande, Qiang Cui, Oliver Soehnlein, Gerard C. L. Wong

PMC · DOI: 10.1073/pnas.2521841122 · Proceedings of the National Academy of Sciences of the United States of America · 2026-01-08

## TL;DR

SARS-CoV-2 produces peptides that selectively target and damage specific immune cells by altering membrane curvature, potentially explaining immune dysregulation in severe COVID-19.

## Contribution

Discovery of a novel mechanism by which SARS-CoV-2 peptides target immune cells via Gaussian curvature, explaining clinical immune cell depletion patterns in severe COVID-19.

## Key findings

- Proteolytic digestion of SARS-CoV-2 proteins generates xenoAMPs with pore-forming activity.
- XenoAMPs selectively deplete immune cells like pDCs and T cells by inducing negative Gaussian curvature in membranes.
- Omicron variant xenoAMPs show reduced pore-forming activity, aligning with milder T cell depletion in Omicron infections.

## Abstract

Previous work has demonstrated that the proteome of SARS-CoV-2 can potentially be a rich source of AMP-like viral fragments, exemplars of which are associated with severe COVID-like inflammation in vitro and in vivo. Here, we demonstrate that direct proteolytic processing of SARS-CoV-2 proteins can yield xenoAMPs, and that the full heterogeneous ensemble of resultant fragments can collectively exert AMP-like pore-forming activity. We describe an unanticipated general mechanism of host cellular targeting for viral AMP-like pore forming peptides, based on local Gaussian curvatures of the host cell membrane, and show that this mechanism can selectively target and deplete specific immune cell types in a manner consistent with clinical observations for severe COVID-19 patients.

Immune cell populations are dysregulated in COVID-19 for currently unknown reasons: Plasmacytoid dendritic cell (pDC) populations are reduced, thus hampering antiviral responses. CD8+ T cell populations are reduced, the level of which has emerged as an index of disease severity. Recent work has shown that the proteome of SARS-CoV-2 is a rich reservoir of antimicrobial peptide-like sequence motifs (xenoAMPs) which can chaperone and organize dsRNA for amplified Toll-Like Receptor 3 (TLR3)-mediated inflammation in vitro and in vivo. Here, we demonstrate that proteolytic digestion of the SARS-CoV-2 spike protein by host trypsin-like serine proteases directly produces xenoAMPs. Synchrotron Small Angle X-ray Scattering, mass spectrometry, and a theoretical analysis based on continuum membrane elasticity show that proteolytically generated xenoAMPs from SARS-CoV-2 proteins in vitro and machine learning-predicted high-scoring xenoAMPs all induce negative Gaussian curvature (NGC) necessary for pore formation in membranes. We find that xenoAMPs alone as well as xenoAMPs synergistically with endogenous AMP LL-37 can induce NGC in membranes. A computational analysis of immune cells with morphologically complex shapes (e.g., pDC, CD8+, and CD4+ T cells) suggests that surfaces with high local NGC can concentrate AMP-like sequences and promote selective membrane disruption. Consistent with this hypothesis, experiments with freshly isolated human peripheral blood mononuclear cells confirm that viable pDCs, DCs, and T cells are significantly depleted after xenoAMP exposure, in contrast to monocytes and neutrophils, the immune cell subsets with spheroidal morphology. Structural data from Omicron variant xenoAMP homologs indicate reduced pore formation, consistent with clinical observations of reduced T cell cytopenia in Omicron variant infections.

## Linked entities

- **Proteins:** CAMP (cathelicidin antimicrobial peptide)
- **Diseases:** COVID-19 (MONDO:0100096)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CAMP (cathelicidin antimicrobial peptide) [NCBI Gene 820] {aka CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** T cell cytopenia (MESH:D016399), inflammation (MESH:D007249), COVID-19 (MESH:D000086382)
- **Chemicals:** AMP (MESH:D000249)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12799121/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12799121/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12799121/full.md

---
Source: https://tomesphere.com/paper/PMC12799121